SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Concord Drugs - Quaterly Results

28 May 2026 Evaluate
The total revenue hovered 346.27% to Rs. 355.63 millions for the March 2026 quarter as against Rs. 79.69 millions during the corresponding quarter last year.The company almost doubled its revenue to Rs. 5.17 millions  from Rs. 0.08 millions in the quarter ended March 2026.Operating profit for the quarter ended March 2026 rose to 14.30 millions as compared to 9.31 millions of corresponding quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 355.63 79.69 346.27 758.83 369.46 105.39 758.83 369.46 105.39
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 14.30 9.31 53.60 42.64 37.77 12.89 42.64 37.77 12.89
Interest 3.45 5.35 -35.51 14.59 17.18 -15.08 14.59 17.18 -15.08
PBDT 10.85 3.96 173.99 28.05 20.59 36.23 28.05 20.59 36.23
Depreciation 3.50 3.75 -6.67 13.57 14.18 -4.30 13.57 14.18 -4.30
PBT 7.35 0.21 3400.00 14.48 6.41 125.90 14.48 6.41 125.90
TAX 2.18 0.13 1576.92 4.11 3.46 18.79 4.11 3.46 18.79
Deferred Tax 0.05 0.19 -73.68 -0.02 1.56 -101.28 -0.02 1.56 -101.28
PAT 5.17 0.08 6362.50 10.37 2.95 251.53 10.37 2.95 251.53
Equity 131.75 100.00 31.75 131.75 100.00 31.75 131.75 100.00 31.75
PBIDTM(%) 4.02 11.68 -65.58 5.62 10.22 -45.03 5.62 10.22 -45.03

Concord Drugs Share Price

79.10 -1.01 (-1.26%)
09-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.40
Dr. Reddys Lab 1268.75
Cipla 1376.75
Zydus Lifesciences 1105.75
Lupin 2263.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×